Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVARTIS PHARMS CORP

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 62
  • 0 comments

FDA approve SECUKINUMAB

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 58
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

SHILPA

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 63
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

SANDOZ INC

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 80
  • 0 comments

FDA approve VORICONAZOLE

Comment Full text

NOVARTIS PHARMS CORP

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 89
  • 0 comments

FDA approve SECUKINUMAB

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 72
  • 0 comments

FDA approve POMALIDOMIDE

Comment Full text

GLAXOSMITHKLINE

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 64
  • 0 comments

FDA approve MEPOLIZUMAB

Comment Full text

MARINUS

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 67
  • 0 comments

FDA approve GANAXOLONE

Comment Full text

FISIOPHARMA

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 66
  • 0 comments

FDA approve SUGAMMADEX SODIUM

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Aug. 08, 2025, 08:25 UTC
  • 57
  • 0 comments

FDA approve FREMANEZUMAB-VFRM

Comment Full text
  • Previous
  • 107
  • 108
  • 109
  • 110
  • 111
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235106)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin